Calon Cardio-Technology Ltd.
Implantable, miniaturized blood pump for advanced heart failure
This article was originally published in Start Up
Executive Summary
Ventricular assist devices are a viable long-term treatment option for patients with advanced heart failure, but their exorbitant price tag and their propensity to damage blood has limited their use. Calon Cardio-Technology Ltd. hopes to avoid those problems with its MiniVAD, which is similar in size and weight to the smallest existing VADs, but is designed to be more efficient and process blood flow more gently.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.